Alaa Sirwi

21PUBLICATIONS
34CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsMolecular targetsGlycoconjugatesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 17, 2026
Fangchinoline (2021-2026): A Multitarget Bisbenzylisoquinoline Alkaloid With Emerging Anti-Infective Potential.

|Jan 26, 2024
RETRACTED: Alhakamy et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977.

Nabil A Alhakamy, Mohammed W Al-Rabia, Shadab Md

|Jul 29, 2023
SIRT1/Nrf2/NF-κB Signaling Mediates Anti-Inflammatory and Anti-Apoptotic Activities of Oleanolic Acid in a Mouse Model of Acute Hepatorenal Damage.

Manea A I Alqrad, Dina S El-Agamy, Sabrin R M Ibrahim

|Jul 29, 2023
Cepabiflas B and C as Novel Anti-Inflammatory and Anti-Apoptotic Agents against Endotoxin-Induced Acute Kidney and Hepatic Injury in Mice: Impact on Bax/Bcl2 and Nrf2/NF-κB Signalling Pathways.

Akaber T Rizq, Alaa Sirwi, Dina S El-Agamy

|Jan 18, 2023
Optimized D-α-tocopherol polyethylene glycol succinate/phospholipid self-assembled mixed micelles: A promising lipid-based nanoplatform for augmenting the antifungal activity of fluconazole.

Shaimaa M Badr-Eldin, Hibah M Aldawsari, Usama A Fahmy

|Jan 08, 2023
Enhancing the Antifungal Activity and Ophthalmic Transport of Fluconazole from PEGylated Polycaprolactone Loaded Nanoparticles.

Alshaimaa M Almehmady, Khalid M El-Say, Manal A Mubarak

Pageof 4

Frequent Collaborators

10 joint publications

Sabrin R M Ibrahim

8 joint publications

Gamal A Mohamed

7 joint publications

Hossam M Abdallah

6 joint publications

Mahmoud A Elfaky